imatinib
for Gastrointestinal stromal tumor

Imatinib is a BCR-ABL tyrosine kinase inhibitor used to treat certain types of leukemia, bone marrow disorders, and skin cancer. It is also prescribed for specific tumors of the stomach and digestive system. Imatinib works by blocking kinases responsible for uncontrolled cell growth, thereby slowing the progression and spread of cancer.

Heart
Medication Guide Icon Medication Guide
New Articles Icon New Articles
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Gastrointestinal stromal tumor - GIST